News

23

Jan2018
SAN DIEGO, CA (January 23, 2018) –— ChemDiv, Inc. announced at the 36th Annual J.P. Morgan Healthcare Conference the expansion ... Read More

22

Jan2018
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6 The company is rapidly expanding the number of ... Read More

04

Jan2018
SAN DIEGO and BONN, Jan. 4, 2017 — The German Center for Neurodegenerative Diseases (DZNE), ChemDiv and Torrey Pines Investment ... Read More

05

Dec2017
Active Biotech (Nasdaq Stockholm: ACTI) today announced initial results from the Phase II proof of concept study of ... Read More